Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma
To investigate efficacy and safety of pemetrexed combined with cisplatin for chemo-naive patients with Malignant Pleural Mesothelioma.
Malignant Pleural Mesotherioma
DRUG: Pemetrexed|DRUG: Cisplatin
To determine the recommended dose of LY231514 and cisplatin combination therapy, Response Rate
Duration of response|Progression free survival|Median survival time|1 year survival rate|Pulmonary function|QOL|Safety|Plasma concentration
To investigate efficacy and safety of pemetrexed combined with cisplatin for chemo-naive patients with Malignant Pleural Mesothelioma.